头颈癌脱水减少(DRIHNC)试验:每日口服液体和电解质维持以预防头颈癌和食管癌放疗患者急性护理诊所和急诊就诊
这项前瞻性先导研究纳入31例接受根治性放疗的头颈癌或食管癌患者,在标准营养咨询外每日给予一瓶20盎司电解质溶液,并与匹配的同期对照队列比较。结果显示干预组急性护理诊所就诊率和静脉输液率显著降低,但脱水相关急诊就诊无显著差异,作者认为该预防方案值得进一步研究。
要点
- 干预组急性护理诊所就诊率32.3% vs 对照组64.5%(P=.02),总就诊次数26 vs 117(P=.002)。
- 干预组静脉输液率35.5% vs 对照组64.5%(P=.004)。
- 脱水相关急诊就诊干预组0例 vs 对照组3例(9.7%),P=.08,无显著差异。
核心结论
- 头颈癌和食管癌根治性放疗期间规律口服水化与急性护理诊所就诊和静脉输液显著减少相关。
- 作者认为这一无创且廉价的预防方案在高风险人群中值得进一步研究。
研究设计与样本
- 前瞻性先导研究,纳入接受根治性放疗的头颈癌或食管癌患者,除标准营养咨询外每日给予一瓶20盎司电解质溶液。
- 与匹配的同期对照队列比较,共31例患者在6个月期间进行比较。
- 采用Fisher精确检验和Wilcoxon秩和检验分别比较结局的发生率和频率。
主要发现
- 平均依从率为87.4%,中位依从率为100%。
- 干预组脱水相关急诊就诊0例 vs 对照组3例(9.7%),P=.08。
- 干预组急性护理诊所就诊率32.3% vs 对照组64.5%(P=.02),总就诊次数26 vs 117(P=.002)。
- 干预组静脉输液率35.5% vs 对照组64.5%(P=.004)。
- 多因素分析中,干预组接受电解质溶液是唯一显著相关的因素(P=.02);食管癌患者中急性护理诊所就诊(P=.003)和静脉输液(P=.008)的差异尤为显著;电解质溶液依从性≥60%者急性护理诊所就诊略少于<60%者(P=.067)。
临床怎么用
- 作者认为在头颈癌和食管癌根治性放疗期间规律口服水化与急性护理诊所就诊和静脉输液显著减少相关。
- 作者认为这一无创且廉价的预防方案在高风险人群中值得进一步研究。
局限性
- 原文结论指出该非侵入性且廉价的预防方案在高风险队列中值得进一步研究。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Patients with head and neck (H&N) and esophageal cancer are at high risk for treatment-related symptomatic dehydration, often leading to interventions and hospital admissions. We tested the hypothesis that preemptive daily oral hydration during curative-intent radiation therapy would decrease dehydration as measured by intravenous fluid (IVF) delivery, acute care clinic (ACC) visits, and emergency department (ED) presentations. METHODS AND MATERIALS: Patients with H&N or esophageal cancer undergoing definitive radiation therapy were enrolled in this prospective pilot study. Beyond standard nutritional counseling, patients were given one 20-oz bottle of an electrolyte-infused solution (EIS) daily throughout treatment. Compliance, presentations to the hospital ACC and/or ED for dehydration-related indications, and IVF infusions were documented and compared with a matched contemporary control cohort. The incidence and frequency of outcomes were compared with the Fisher exact test and Wilcoxon rank-sum test, respectively. RESULTS: Thirty-one patients were compared during a 6-month period. Mean and median compliance rates were 87.4% and 100%, respectively. There were 0 unplanned dehydration-related ED presentations in the study group versus 3 (9.7%) among controls (P = .08). Of patients in the intervention cohort, 32.3% required presentation to the ACC, versus 64.5% in the control cohort (P = .02), with a total of 26 versus 117 visits, respectively (P = .002). On multivariable analysis, receipt of the EIS in the intervention cohort was the only significantly associated factor (P = .02). Among patients in the intervention cohort, 35.5% required IVF during treatment, versus 64.5% among controls (P = .004). The difference in ACC visits (P = .003) and IVF received (P = .008) was especially notable among patients with esophageal cancer. Patients with ≥60% EIS compliance had slightly fewer ACC visits versus those with <60% compliance (P = .067). CONCLUSIONS: Regimented oral hydration during radiation for H&N and esophageal cancer was associated with a significant decrease in ACC visits and IVF delivery during definitive radiation therapy. This noninvasive and inexpensive preventative program in a high-risk cohort warrants further study.
引用
- Fredman E, Kharouta M, Chen E, et al. Dehydration Reduction in Head and Neck Cancer (DRIHNC) Trial: Daily Oral Fluid and Electrolyte Maintenance to Prevent Acute Care Clinic and Emergency Department Visits for Patients Receiving Radiation for Head and Neck and Esophageal Cancer. Adv Radiat Oncol. 2022. PMID: 36420199. doi:10.1016/j.adro.2022.101026
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。